Summit Therapeutics Stock Forecast

Stock Price Forecast

According to 16 professional analysts, the 12-month price target for Summit Therapeutics stock ranges from a low of $12 to a high of $44. The average analyst price target of $33.63 forecasts a 83.67% increase in the stock price over the next year.

Price Target: $33.63 (+83.67%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$12	$33.63	$40	$44
Change	-34.46%	+83.67%	+118.46%	+140.31%

* Price targets were last updated on Oct 22, 2025.

Analyst Ratings

The average analyst rating for Summit Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	8	9	10	9	9	9
Buy	4	5	5	5	5	5
Hold	0	1	1	1	2	2
Sell	1	1	2	2	2	2
Strong Sell	0	0	0	0	0	0
Total	13	16	18	17	18	18

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kalpit Patel Wolfe Research	Wolfe Research	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Nov 18, 2025
Brad Canino Guggenheim	Guggenheim	Strong Buy Reiterates $40	Strong Buy	Reiterates	$40	+118.46%	Oct 22, 2025
Etzer Darout Barclays	Barclays	Sell Maintains $13 → $16	Sell	Maintains	$13 → $16	-12.62%	Oct 21, 2025
Mitchell S. Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $50 → $40	Strong Buy	Maintains	$50 → $40	+118.46%	Oct 21, 2025
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $35 → $40	Strong Buy	Maintains	$35 → $40	+118.46%	Oct 20, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

18.90M

EPS This Year

-1.23

from -0.31

EPS Next Year

-0.99

from -1.23

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	860.00K	1.81M	705.00K	-	-	-	18.90M
Revenue Growth	6.10%	110.35%	-61.03%	-	-	-	-
EPS	-0.76	-0.96	-0.41	-0.99	-0.31	-1.23	-0.99
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	19	18

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	86.1M
Avg	n/a	18.9M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-0.14	-0.59
Avg	-1.23	-0.99
Low	-1.45	-1.53

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.